Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
about
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population.MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers
P2860
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
@en
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
@nl
type
label
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
@en
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
@nl
prefLabel
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
@en
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
@nl
P2093
P2860
P356
P1433
P1476
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
@en
P2093
Guoqing Ru
Junqiang Chen
Riping Chen
Wanyuan Chen
Xianglei He
Xianhong Yin
Xing Zhang
P2860
P304
P356
10.1155/2017/5756102
P577
2017-03-01T00:00:00Z